Skip to main content

GeneDx Holdings Corp.

WGS
Exchange
Nasdaq
Industry
Services-Health Services
SEC CIK
0001818331

In the last 90 days, GeneDx Holdings Corp. insiders filed 0 open-market purchases and 5 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $2.17B in total; ARK Invest is the only superinvestor holding it.

Key figures

Market capClose on Nov 16, 2026
$1.53B
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $1.84M in total
5
13F holdersQ2 2026, −16 vs. previous quarter
226
13F valueReported value at the end of Q2 2026
$2.17B
Superinvestors holdingAt the end of Q2 2026
1

Price chart

From SEC filings, in USD.

Revenue, FY2025
$427.5M
+40.0% year over year
Net income, FY2025
-$21.0M
No comparable prior period
Free cash flow, FY2025
$14.3M
No comparable prior period
Revenue, Q3 FY2026
$123.1M
+5.4% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $21.0M (4.9% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
6.55M
Shares sold short
Change
+531.8K
+8.8% vs. previous
Days to cover
7.27
At average daily volume

Superinvestors holding WGS, Q2 2026

Go to the superinvestors tab

1 superinvestor reports holding GeneDx Holdings Corp. on Form 13F. Percentages are the stock's share of each portfolio.

ARK Invest

Cathie Wood

0.7%

GeneDx Holdings Corp.'s share of the portfolio

Shares
1,610,189
Value
$110.5M

Latest insider trades

See all insider trades

Open-market purchases and sales by GeneDx Holdings Corp. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 18, 2026 (view filing)4:43 PM ETSep 162 daysStueland KatherineCHIEF EXECUTIVE OFFICERSSaleClass A Common Stock−10.5K$97.61−$1.03M−8.3%115.5K after5 lots
Sep 18, 2026 (view filing)4:39 PM ETSep 162 daysFeeley KevinCHIEF FINANCIAL OFFICERSSaleClass A Common Stock−3.73K$97.61−$363.9K−7.7%44.9K after5 lots
Sep 11, 2026 (view filing)4:13 PM ETSep 92 daysStueland KatherineCHIEF EXECUTIVE OFFICERSSaleClass A Common Stock−3.69K$84.22−$310.9K−3.3%107.2K after
Sep 11, 2026 (view filing)4:10 PM ETSep 92 daysFeeley KevinCHIEF FINANCIAL OFFICERSSaleClass A Common Stock−1.28K$84.22−$108.2K−3.0%41.5K after
Sep 3, 2026 (view filing)4:09 PM ETSep 12 daysFeeley KevinCHIEF FINANCIAL OFFICERSSaleClass A Common Stock−372$83.84−$31.2K−0.9%40.3K after
Jun 18, 2026 (view filing)Jun 162 daysFeeley KevinCHIEF FINANCIAL OFFICERSSaleClass A Common Stock−3.73K$60.76−$226.6K−8.5%40.0K after3 lots
Jun 18, 2026 (view filing)Jun 162 daysStueland KatherineCHIEF EXECUTIVE OFFICERSSaleClass A Common Stock−10.5K$60.76−$638.1K−9.1%104.4K after3 lots
Jun 11, 2026 (view filing)Jun 92 daysFeeley KevinCHIEF FINANCIAL OFFICERSSaleClass A Common Stock−1.27K$53.77−$68.1K−3.4%36.5K after
Jun 11, 2026 (view filing)Jun 92 daysStueland KatherineCHIEF EXECUTIVE OFFICERSSaleClass A Common Stock−3.64K$53.77−$195.7K−3.6%96.1K after
Jun 8, 2026 (view filing)5:25 PM ETJun 4-54 daysCasdin Partners GP, LLC and 3 othersDirector, 10% OwnerPPurchaseClass A Common Stock, par value $0.0001 per share+200.0K$55.55+$11.1M+5.7%3.71M after2 lots

Top 10 13F holders, Q2 2026

See all 226 holders

The largest institutional positions in GeneDx Holdings Corp. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding WGS in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Corvex Management LP4,784,570$328.5M10.21%+1,556,421+48.2%Added
Casdin Capital, LLC3,707,164$254.5M12.74%+700,000+23.3%Added
BlackRock, Inc.1,706,239$117.1M0.00%+155,531+10.0%Added
Goldman Sachs Group Inc1,669,441$114.6M0.01%+334,461+25.1%Added
ARK Investment Management LLCSuperinvestorARK Invest1,610,189$110.5M0.72%+285,606+21.6%Added
William Blair Investment Management, LLC1,400,653$96.2M0.29%+625,384+80.7%Added
Morgan Stanley988,297$67.8M0.00%+456,062+85.7%Added
Vanguard Capital Management LLC879,003$60.3M0.00%+20,420+2.4%Added
Citadel Advisors LLC865,462$59.4M0.03%+218,061+33.7%Added
First Light Asset Management, LLC783,923$53.8M3.27%+540,996+222.7%Added

Holders of 5% or more of WGS

See all 5 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of GeneDx Holdings Corp..

Largest holders of WGS from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
CMLS Holdings LLC13D/A17.90%5.36M shares0.00 ppfrom 17.90%Feb 16, 202114 filingsMay 22, 2026SEC
ARK Investment Management LLCSuperinvestorARK Invest13G/A6.42%1.91M shares+1.09 ppfrom 5.33%Jul 9, 20213 filingsNov 13, 2026SEC
Goldman Sachs Group Inc13G5.80%1.73M shares+1.90 ppfrom 3.90%Feb 9, 20245 filingsAug 11, 2026SEC
BlackRock, Inc.13G5.50%1.62M sharesNewJul 28, 20261 filingJul 28, 2026SEC
William Blair Investment Management, LLC13G5.20%1.56M shares+0.90 ppfrom 4.30%Jul 30, 20253 filingsNov 6, 2026SEC